Studies of cancer biology and genom-ics have mainly focused on recurrent driver mutations in key oncogenes and tumour suppressor genes, as these are known to have major roles in tumorigenesis and cancer progression. However, these driver mutations are vastly outnumbered by passenger mutations, which are often assumed to be biologically neutral. A new computational study suggests that passenger mutations may have detrimental effects on tumour fitness, with therapeutic implications.
展开▼
